← FDA Drug Approvals (Drugs@FDA)

BLEOMYCIN SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2001-10-17

Drug application

FDA Application #
ANDA065042
Application type
Abbreviated New Drug Application (Generic)
Brand name
BLEOMYCIN SULFATE
Generic name
BLEOMYCIN
Active ingredients
BLEOMYCIN SULFATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
HIKMA
Manufacturer
Hikma Pharmaceuticals USA Inc.
First approval
2001-10-17

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown